TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34062976

Group type: EXPERIMENTAL
Intervention: Aguamiel-based beverage fermented with Lactobacillus plantarum, Lactobacillus paracasei and Lactobacillus brevis (100 mL, 3 × 10^8 cfu/mL) for 8 weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (placebo intervention)
Number of subjects: 27
Study: 33986484

Group type: EXPERIMENTAL
Intervention: Dental Practicality Index (DPI) training
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (no DPI training)
Number of subjects: 108
Study: 32860109

Group type: EXPERIMENTAL
Intervention: PAP (piperacillin/tazobactam)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90

Group type: COMPARATOR
Intervention: PAP and Placebo
Number of subjects: 90
Study: 35430800

Group type: EXPERIMENTAL
Intervention: Regular exercise rehabilitation guided by 6-minute walk test (6-MWT) for 12 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: No exercise rehabilitation
Number of subjects: 100
Study: 33534134

Group type: EXPERIMENTAL
Intervention: Everolimus (EVE)
Number of subjects: 45
Study: 32784847

Group type: COMPARATOR
Intervention: Whey protein supplementation
Number of subjects: 92

Group type: COMPARATOR
Intervention: Pea protein supplementation
Number of subjects: 92

Group type: COMPARATOR
Intervention: Whey protein vs Pea protein
Number of subjects: 92

Group type: COMPARATOR
Intervention: Whey and Pea protein vs Water supplementation
Number of subjects: 92
Study: 33119924

Group type: EXPERIMENTAL
Intervention: Relief/habit drinkers
Number of subjects: 184

Group type: COMPARATOR
Intervention: Reward drinkers
Number of subjects: 184
Study: 32362132

Group type: EXPERIMENTAL
Intervention: HiBalance intervention (10-week, two times weekly progressive balance training led by physical therapists)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: HiBalance intervention
Number of subjects: 117
Study: 35623183

Group type: EXPERIMENTAL
Intervention: High-dose inhaled nitric oxide (iNO) at 250 ppm for 30 minutes
Number of subjects: 47

Group type: COMPARATOR
Intervention: Supportive care only (control group)
Number of subjects: 47
Study: 33730350

Group type: EXPERIMENTAL
Intervention: Afatinib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sequential afatinib followed by osimertinib
Number of subjects: 0
Study: 35184413

Group type: EXPERIMENTAL
Intervention: Apatinib 500 mg once daily
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Combination of apatinib and melittin
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Apatinib and melittin
Number of subjects: 17
Study: 34191841

Group type: EXPERIMENTAL
Intervention: Improved choice experiment method for soil fertility management technologies
Number of subjects: 962
Study: 35050320

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (2 mg/kg or 10 mg/kg every 2 or 3 weeks)
Number of subjects: 575

Group type: COMPARATOR
Intervention: Standard method (Response Evaluation Criteria in Solid Tumors 1.1)
Number of subjects: 575
Study: 33602745

Group type: EXPERIMENTAL
Intervention: DISORDER motion correction
Number of subjects: 32
Study: 2010154965

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injections (BTIs)
Number of subjects: 15
Study: 35504809

Group type: EXPERIMENTAL
Intervention: Thickness-based protocol for imaging (intervention cohort)
Number of subjects: 455

Group type: COMPARATOR
Intervention: Standard imaging protocol (baseline cohort)
Number of subjects: 455
Study: 34618311

Group type: EXPERIMENTAL
Intervention: Thula Baba Box (TBB) and community health worker (CHW) programme
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 72
Study: 35368773

Group type: EXPERIMENTAL
Intervention: Tongdu Bushen acupuncture, intradermal acupuncture, and moxibustion integrated therapy combined with core muscle training program (CMT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Electroacupuncture combined with the CMT
Number of subjects: 120
Study: 32063406

Group type: EXPERIMENTAL
Intervention: Increase in total physical activity (PA)
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Increase in moderate physical activity
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Increase in moderate-to-vigorous physical activity
Number of subjects: 489
Study: 35792788

Group type: EXPERIMENTAL
Intervention: 8% arginine toothpaste
Number of subjects: 72

Group type: COMPARATOR
Intervention: Regular fluoride toothpaste
Number of subjects: 72
Study: 34518159

Group type: EXPERIMENTAL
Intervention: HEAL-D (culturally tailored T2D self-management education and support program); 7 sessions, 14 hours of group-based education, behavior change support, and supervised physical activity.
Number of subjects: 55

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 55
Study: 33482385

Group type: EXPERIMENTAL
Intervention: Unsupervised at-home cardiovascular exercise program for 6 months
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 77
Study: 32608315

Group type: EXPERIMENTAL
Intervention: Electromagnetic navigation (EMN) for cup placement at predetermined angles (inclination: 42.5°; anteversion: 15°)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Freehand technique for cup placement aiming at the same target angles
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Electromagnetic navigation (EMN)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Freehand technique
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Electromagnetic navigation (EMN) and Freehand technique
Number of subjects: 84
Study: 36177926

Group type: EXPERIMENTAL
Intervention: Xiaoqinglong Decoction (1 000 mg/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Qingqi Huatan Pill (1 000 mg/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PDTC (100 μmol/L)
Number of subjects: 0
Study: 33759250

Group type: EXPERIMENTAL
Intervention: Emodepside as LSF, single oral administration of 20 mg
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Emodepside as LSF, multiple oral administration over 10 days at 5 mg once daily and 10 mg once daily and 10 mg twice daily
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Emodepside as IR tablet, 5 or 20 mg
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Emodepside as LSF, doses from 1 to 40 mg
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Emodepside as LSF
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Emodepside as LSF, fed state
Number of subjects: 103
Study: 32201234

Group type: EXPERIMENTAL
Intervention: Durvalumab (10 mg/kg every 2 weeks for up to 12 months)
Number of subjects: 595

Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: Durvalumab + Tremelimumab (12 weeks durvalumab 20 mg/kg + tremelimumab 1 mg/kg q4w then 34 weeks durvalumab 10 mg/kg q2w)
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: Durvalumab + Tremelimumab
Number of subjects: 595
Study: 35734420

Group type: EXPERIMENTAL
Intervention: Hatha yoga
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Restorative yoga
Number of subjects: 49

Group type: COMPARATOR
Intervention: Both yoga interventions
Number of subjects: 49
Study: 33289149

Group type: EXPERIMENTAL
Intervention: Postoperative decrease of albumin (ΔAlb) calculated on postoperative day 1, with a cut-off established at 11 g/L.
Number of subjects: 1046

Group type: EXPERIMENTAL
Intervention: Higher BMI and laparoscopy as factors associated with lower ΔAlb.
Number of subjects: 1046
Study: 36344108

Group type: EXPERIMENTAL
Intervention: IVC and lung ultrasound-guided decongestion therapy
Number of subjects: 58

Group type: COMPARATOR
Intervention: Clinical-guided decongestion therapy
Number of subjects: 58
Study: 33063862

Group type: EXPERIMENTAL
Intervention: Galcanezumab 120 mg
Number of subjects: 2886

Group type: EXPERIMENTAL
Intervention: Galcanezumab 240 mg
Number of subjects: 2886

Group type: COMPARATOR
Intervention: Galcanezumab
Number of subjects: 2886
Study: 35420245

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention (supportive counseling and facilitated referrals)
Number of subjects: 140
Study: 33928857

Group type: EXPERIMENTAL
Intervention: Corticosteroid Injection (CI)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Percutaneous Release of the A1 Pulley (PTFR)
Number of subjects: 83
Study: 35302400

Group type: EXPERIMENTAL
Intervention: Supervised endurance/resistance exercise for 24 weeks
Number of subjects: 49
Study: 33709920

Group type: EXPERIMENTAL
Intervention: Continuous care model (CCM) lifestyle intervention over 4 months
Number of subjects: 50
Study: 34637505

Group type: EXPERIMENTAL
Intervention: High-protein milk-cereal mix (5.6 g protein, PER: 18%, 1.68 g from milk source)
Number of subjects: 1548

Group type: COMPARATOR
Intervention: Modest-protein milk-cereal mix (2.5 g protein, PER: 8%; 0.75 g from milk source)
Number of subjects: 1548
Study: 34423388

Group type: EXPERIMENTAL
Intervention: Mechanical vibration (50 Hz, 10 min/day for 12 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no vibration)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Force application
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mechanical vibration
Number of subjects: 20
Study: 32390309

Group type: EXPERIMENTAL
Intervention: 5% Benzoyl Peroxide (BPO), twice a day
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combination of 5% BPO + 3% Erythromycin, twice a day
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combination of 4% Niacinamide + 1% Gallic Acid + 1% Lauric Acid, twice a day
Number of subjects: 90
Study: 36303217

Group type: EXPERIMENTAL
Intervention: Unpaid social media recruitment methods (no financial cost)
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Paid Facebook advertisements (£259.93 total cost, £2.11 per participant)
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Other recruitment methods
Number of subjects: 296
Study: 33147332

Group type: EXPERIMENTAL
Intervention: Anterior approach
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional hepatectomy
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Detection of CTC
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Disease-free survival
Number of subjects: 80
Study: 32792431

Group type: EXPERIMENTAL
Intervention: Incremental haemodialysis (2 days a week)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional haemodialysis (3 times a week)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Incremental haemodialysis
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional haemodialysis
Number of subjects: 54
Study: 35931964

Group type: EXPERIMENTAL
Intervention: Educational intervention program based on Health Belief Model (HBM)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 146
Study: 36376310

Group type: EXPERIMENTAL
Intervention: Third dose of CoronaVac at a 10-month interval (cohort 1)
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Third dose of CoronaVac at a 12-month interval (cohort 2)
Number of subjects: 384

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 384
Study: 34756882

Group type: EXPERIMENTAL
Intervention: Alectinib 600 mg twice daily
Number of subjects: 303

Group type: COMPARATOR
Intervention: Crizotinib 250 mg
Number of subjects: 303
Study: 35854358

Group type: EXPERIMENTAL
Intervention: 1-h music listening sessions twice daily through noise-canceling headphones
Number of subjects: 160

Group type: COMPARATOR
Intervention: 1-h sessions of a silence track twice daily through noise-canceling headphones
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 160

Group type: COMPARATOR
Intervention: Silence track attention control
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Follow-up after hospital discharge
Number of subjects: 160
Study: 33737417

Group type: EXPERIMENTAL
Intervention: Gamma Knife Radiosurgery (GKRS) within 2 months following randomisation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conservative management (CM)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Gamma Knife Radiosurgery (GKRS)
Number of subjects: 100
Study: 34145042

Group type: EXPERIMENTAL
Intervention: FICare
Number of subjects: 455
Study: 34956191

Group type: EXPERIMENTAL
Intervention: DMPA-IM
Number of subjects: 97

Group type: COMPARATOR
Intervention: NET-EN
Number of subjects: 97
Study: 35483010

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy followed by chemoradiotherapy (INCT‐CRT)
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy followed by consolidation chemotherapy (CRT‐CNCT)
Number of subjects: 324
Study: 34913976

Group type: EXPERIMENTAL
Intervention: Values affirmation writing exercise
Number of subjects: 960

Group type: COMPARATOR
Intervention: Control writing exercise
Number of subjects: 960
Study: 32649011

Group type: EXPERIMENTAL
Intervention: Elective Caesarean section at early-term (38+3 weeks)
Number of subjects: 574

Group type: COMPARATOR
Intervention: Elective Caesarean section at full-term (39+3 weeks)
Number of subjects: 574
Study: 32773296

Group type: EXPERIMENTAL
Intervention: Retroperitoneal laparoscopic approach
Number of subjects: 344

Group type: COMPARATOR
Intervention: Transperitoneal laparoscopic approach
Number of subjects: 344
Study: 32354280

Group type: EXPERIMENTAL
Intervention: Eplerenone treatment
Number of subjects: 6632
Study: 35684021

Group type: EXPERIMENTAL
Intervention: RiaGev (Nicotinamide and D-Ribose) 1520 mg twice daily for 7 days
Number of subjects: 0
Study: 33754416

Group type: COMPARATOR
Intervention: Small number of reward points for dementia prevention activities
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Time credits for support activities
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Small cash reward for support activities
Number of subjects: 1500

Group type: COMPARATOR
Intervention: No incentives for support activities
Number of subjects: 1500
Study: 32120378

Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 1519

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 1519
Study: 36123654

Group type: EXPERIMENTAL
Intervention: Confederate group
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 63
Study: 33620439

Group type: EXPERIMENTAL
Intervention: ≥50% of the target β-blocker dose
Number of subjects: 97575

Group type: COMPARATOR
Intervention: <50% of the target β-blocker dose
Number of subjects: 97575
Study: 32331073

Group type: EXPERIMENTAL
Intervention: OLZ/SAM
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 36440867

Group type: EXPERIMENTAL
Intervention: Vibration bee with cold
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Whistling (concentrate on breathing)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 33515432

Group type: EXPERIMENTAL
Intervention: Untargeted metabolomics using LC-MS/MS on newborn screening dried blood spot (DBS) samples
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Gestational age, age at sampling, and month of birth
Number of subjects: 37
Study: 32345747

Group type: EXPERIMENTAL
Intervention: Nicotinamide and lanthanum carbonate
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Baseline ADC (apparent diffusion coefficient)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Baseline ADC (after adjustment for albuminuria)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Baseline R2* (relaxation rate)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Follow-up functional MRI (87 participants)
Number of subjects: 122
Study: 34801508

Group type: EXPERIMENTAL
Intervention: Simulator-based training (n=17)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Traditional training (n=16)
Number of subjects: 33
Study: 32094049

Group type: EXPERIMENTAL
Intervention: Gentamicin implant
Number of subjects: 288

Group type: COMPARATOR
Intervention: Control group (no implant)
Number of subjects: 288
Study: 34410393

Group type: EXPERIMENTAL
Intervention: Pictorial information on carotid ultrasonographic determination of vascular age
Number of subjects: 3532

Group type: COMPARATOR
Intervention: No pictorial information (Control)
Number of subjects: 3532
Study: 32326948

Group type: EXPERIMENTAL
Intervention: Individual VR
Number of subjects: 289

Group type: COMPARATOR
Intervention: Individual TP
Number of subjects: 289
Study: 34280377

Group type: EXPERIMENTAL
Intervention: Female patients
Number of subjects: 1212487
Study: 33628801

Group type: EXPERIMENTAL
Intervention: 2.7% wt. monopotassium‐monohydrogen oxalate (Mp‐Mh oxalate)
Number of subjects: 42

Group type: COMPARATOR
Intervention: RMGI XT VAR
Number of subjects: 42

Group type: COMPARATOR
Intervention: LIQ SiO2
Number of subjects: 42
Study: 35522534

Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition (early-PN)
Number of subjects: 614

Group type: COMPARATOR
Intervention: Late parenteral nutrition (late-PN)
Number of subjects: 614
Study: 33932526

Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training (HIIT)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Stretching (active control)
Number of subjects: 53
Study: 35810479

Group type: EXPERIMENTAL
Intervention: Placebo treatment (sham acupuncture)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 90
Study: 33239152

Group type: EXPERIMENTAL
Intervention: Inhaled control medication (ICM)
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Short-acting beta-agonists (SABA)
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: SABA
Number of subjects: 442
Study: 35185010

Group type: EXPERIMENTAL
Intervention: Percutaneous transforaminal endoscopic discectomy (PTED)
Number of subjects: 613

Group type: COMPARATOR
Intervention: Open microdiscectomy
Number of subjects: 613
Study: 33692404

Group type: EXPERIMENTAL
Intervention: Educational Nutrition intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: WASH/Malaria intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Test-and-treat intervention
Number of subjects: 0
Study: 33627253

Group type: EXPERIMENTAL
Intervention: Low serum MBL (≤100 μg/L)
Number of subjects: 7305

Group type: EXPERIMENTAL
Intervention: Low MBL expression genotype
Number of subjects: 7305
Study: 32176862

Group type: EXPERIMENTAL
Intervention: Moderate-exercise (EEex goal of 17.5 kcal/kg/wk)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High-exercise (EEex goal of 35 kcal/kg/wk)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Observation group
Number of subjects: 60
Study: 34000251

Group type: EXPERIMENTAL
Intervention: Estetrol (E4) 15 mg and drospirenone (DRSP) 3 mg
Number of subjects: 1864
Study: 32500130

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Physical Therapy (PT)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Back Pain Education (Control)
Number of subjects: 320
Study: 34856577

Group type: EXPERIMENTAL
Intervention: Expectant management
Number of subjects: 5759

Group type: COMPARATOR
Intervention: Induction of labor
Number of subjects: 5759
Study: 32690640

Group type: EXPERIMENTAL
Intervention: rhu-pGSN single-dose at 6 mg/kg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: rhu-pGSN multidose at 6, 12, or 24 mg/kg for 3 consecutive days
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo single-dose
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo multidose
Number of subjects: 33
Study: 35882692

Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC) based HIPEC
Number of subjects: 137

Group type: COMPARATOR
Intervention: Oxaliplatin based HIPEC
Number of subjects: 137
Study: 33146720

Group type: EXPERIMENTAL
Intervention: Matrix‐M–adjuvanted qNIV
Number of subjects: 1375

Group type: COMPARATOR
Intervention: IIV3‐HD
Number of subjects: 1375

Group type: COMPARATOR
Intervention: RIV4
Number of subjects: 1375
Study: 34611470

Group type: EXPERIMENTAL
Intervention: omalizumab
Number of subjects: 608

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 608
Study: 35839439

Group type: EXPERIMENTAL
Intervention: Combination cognitive behavioral therapy and medication management algorithm
Number of subjects: 156

Group type: COMPARATOR
Intervention: Enhanced standard of care (psychotherapy and medication management)
Number of subjects: 156
Study: 34948650

Group type: EXPERIMENTAL
Intervention: Vitamin D status (25(OH)D)
Number of subjects: 1864
Study: 35778701

Group type: EXPERIMENTAL
Intervention: Recruitment Maneuver (RM) with 6 cm H2O PEEP
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (C) with 6 cm H2O PEEP and no RM
Number of subjects: 42
Study: 33688711

Group type: EXPERIMENTAL
Intervention: Shadent software
Number of subjects: 250

Group type: COMPARATOR
Intervention: Visual method
Number of subjects: 250

Group type: COMPARATOR
Intervention: Spectrophotometer
Number of subjects: 250
Study: 32546139

Group type: EXPERIMENTAL
Intervention: Mindfulness-based relapse prevention + real-time fMRI neurofeedback targeting ventral striatum
Number of subjects: 88

Group type: COMPARATOR
Intervention: Mindfulness-based relapse prevention + real-time fMRI neurofeedback targeting auditory cortex (control)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Real-time fMRI neurofeedback targeting ventral striatum
Number of subjects: 88

Group type: COMPARATOR
Intervention: Real-time fMRI neurofeedback targeting auditory cortex (control)
Number of subjects: 88
Study: 34510174

Group type: EXPERIMENTAL
Intervention: High-spice diet (HSD) 6.6 g/d/2100 kcal
Number of subjects: 71

Group type: COMPARATOR
Intervention: Moderate-spice diet (MSD) 3.3 g/d/2100 kcal
Number of subjects: 71

Group type: COMPARATOR
Intervention: Low-spice diet (LSD) 0.5 g/d/2100 kcal
Number of subjects: 71
Study: 33296878

Group type: EXPERIMENTAL
Intervention: Novel automatic algorithm for diagnosing sleep apnea from nasal airflow (AF) and pulse oximetry (SpO2) signals
Number of subjects: 988

Group type: COMPARATOR
Intervention: Scored SHHS data
Number of subjects: 988
Study: 36075583

Group type: EXPERIMENTAL
Intervention: Reminiscence therapy (RT) using digital material or storytelling for 4 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reminiscence therapy (RT)
Number of subjects: 0
Study: 34242960

Group type: EXPERIMENTAL
Intervention: 2019 survey participants
Number of subjects: 1588